Skip to main content

Investor Relations

Welcome to our dedicated page for investor resources. You will find everything you need if you want to invest in pioneering medical science.

Dedicated to solving some of today’s biggest public health challenges, bioMérieux has the focus and the capabilities to discover, develop, and commercialize advanced medical diagnostics solutions that have an impact on people’s lives. We combine the dynamism of a technology-fueled company with the long-term thinking of our founding family. It is this alliance that shapes our strategy and success.

A values-based company, we aim for strong and sustainable performance that benefits our shareholders, our employees, and society.


2023 H1 Financial Results

  • €1,770 million in the first-half 2023 sales, up 8.3% like-for-like, organic growth excluding respiratory panels amounts to +11%, slightly ahead of the full- year sales growth guidance excluding respiratory panels of +8%-+10%
  • Q2 sales organic growth at +9.2% driven by a strong momentum in clinical microbiology (+18%) and BIOFIRE® non-respiratory panels (+23%) combined with a solid growth in industrial applications (+10%)
  • Contributive operating income before non-recurring items reached €291 million (16.5% of sales) for the first half of the year, decreasing by 1.5% like for like versus H1 2022, as expected
  • Promising start of the new BIOFIRE® SPOTFIRE®, VIDAS® KUBE™ and VITEK® REVEAL™ instruments and a very positive trend for VITEK® MS PRIME.

“bioMérieux performed well in the first half of 2023, in line with its targets, illustrating the relevance of our product portfolio to support the fight against infectious diseases and antimicrobial resistance. In addition, we have successfully launched several new products, that will reinforce our leadership in the market. We do confirm our annual guidance”

Pierre Boulud, CEO

Working at home with laptop woman writing a blog. Female hands on the keyboard.

URD/Annual Reports

See most comprehensive information about bioMérieux.


Discover our plans to a sustainable future.


Our boards and committees underpin our ability to make decisions and ensure control processes. 

Working at home with laptop woman writing a blog. Female hands on the keyboard.

News & publications

bioMérieux combines long-term growth and profitability. Learn more about our performance and activities in our detailed reports and financials.

Analysts coverage & consensus

Financial analysts keep track of our performance. Discover their forecasts here.

Shareholder Area

Already a bioMérieux shareholder or want to start investing?

Close up Business people meeting to discuss the situation on the market. Business Financial Concept

Regulated Information

To guarantee transparency and sustainability, we abide by a strict set of rules and regulations.